Four-Front Defense: Flu, Pneumococcal, RSV and COVID-19 Vaccines
Join our experts in this FREE 60-minute webinar discussing the essential respiratory vaccines, co-developed by CTS and Respiplus.
This webinar will cover four key respiratory immunizations - RSV, pneumococcal, influenza, and COVID-19 - providing attendees with up-to-date information on vaccine efficacy, safety profiles, and administration guidelines. Beyond the clinical aspects, we'll touch on the pressing issues of vaccine hesitancy and fatigue, offering evidence-based approaches to overcome these challenges.
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program (MOC) of The Royal College of Physicians and Surgeons of Canada and approved by the Canadian Thoracic Society. Live webinar participants may claim a maximum of 1 hour.
After attending the session, participants will be able to:
Distinguish between RSV, pneumococcal disease, influenza, and COVID-19 in terms of causative agents, transmission, and general epidemiology.
Interpret the current recommendations for each vaccine, including target populations and dosing schedules.
Discuss the vaccine effectiveness and safety to allow for a benefit-risk discussion for vaccination.
Summarize strategies to address vaccine hesitancy in a patient who is a candidate for respiratory vaccines.
Discuss a multidisciplinary, collaborative approach to increasing respiratory vaccine uptake.
This program has received funding from GSK and Moderna. It is planned to achieve scientific integrity, objectivity and balance.
This webinar is only for healthcare professionals.
RPh, CDE, CBE
MDCM, CCFP, FCFP, MSCP